The FIRST and ONLY lash treatment … LATISSE … approved by the FDA indicated to treat hypotichosis of the eyelashes by increasing their growth including length, thickness, and darkness. 

 When 278 adults were treated for four months, 78% of patients reported overall lash improvement and prominence by week 16.  At week 16, the tested group reported 106% increased fullness and thickness from their baseline lashes.   

The most frequently reported adverse side affects were ocular irritation, conjunctival hyperemia, and dry eyes.  These event occurred in less than 4% of patients tested.  Check with your physician for additional information on adverse affects.

Put your best lash forward … call today to learn more about the daily application of Latisse offered by Allergan.  For more information, read the Latisse section of this website under procedures tab.  

** Statistics reported in 2009 by Allergan, Inc Irvine, California  

Tags: eyelash solution, latisse

This entry was posted on Tuesday, August 25th, 2009 at 7:49 am and is filed under Latisse Eyelash Solution. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.